Nordic AML ‘poster walk’ post-ASH

Nordic AML posters at ASH 2023 - Webinar - 2024-03-12 - 15:00-16:20 (CET) Join us for a webinar where we delve into the intricacies of showcased Nordic AML posters at the latest ASH Annual Meeting in December 2023. Here we aim for an opportunity to gain valuable insights, connect with peers, and stay at the […]

CCBIO Seminar – Mika Kontro – Functional Screening for Precision Medicine Approaches in AML

Dr. Mika Kontro will discuss the methods for personalizing AML therapies using functional screening. He will provide an overview of the current data implementation and share insights from ongoing prospective trials employing functional screening. Furthermore, Dr. Kontro will focus on the VenEx trial, which utilizes ex vivo drug sensitivity testing to identify AML patients who […]

Nordic MPAL meeting

For more information, please contact Vladimir Lazarevic, Lund, Sweden. Join via Teams using this link.  

EHA Meeting: Nordic Lunch meeting

NAMLG lunch meeting to be held in Sponsor Meeting Hub (in Hall 9) between 11:30 and 13:30 on Saturday 15th June. Preliminary agenda 11:30-11:35: Welcome, v. Bjørn-Tore Gjertsen, Chairman 11:35-11:45 Remarks from the sponsor v. Delbert Pharma 11:45-12:25: NAMLG activities: 11:45-11:55: Scientific working group, Sören Lehmann 11:55-12:05: Educational working group, Albin Österroos/Daniel Tuyet Kristensen 12:05-12:25: […]

Workshop & Talks: Nanopore Sequencing Technologies

Find more information via this link. Join the workshop online, by using this Zoom link: https://nanoporetech.zoom.us/j/88211217159?pwd=vlPpfbolZ8bd9kQgQ4Vdi5kytU7Bbb.1 Passcode: 145047 or join in place at this location: Auditorium 2 & 4, BB-Bygget. Haukeland Universitetssykehus - Jonas Lies vei 91. 5009 Bergen

Webinar – Azacitidine-Venetoclax: latest clinical updates

The NAMLG’s Educational Working Group is hosting a webinar on September 24, 2024, from 15:00 to 16:30 CEST. The webinar will provide the latest insights on using Aza-Ven in AML treatment including discussions from a Nordic perspective. Topics will include its application as a first-line treatment, dosing optimizations, and strategies for maintenance therapy. You can […]

mIDH1-mutated AML: ivosidenib in clinical practice

This Servier arranged webinar is for hematologists. The agenda for the webinar is: 12:00-12:05 – Introduction by Erik Holgén, Product Manager, Servier 12:05-12:30 – Prof. Dr. Michael Heuser - Will present the AGILE study and the clinical implications of the study results. 12:30-12:45 – Docent Vladimir Lazarevic - Focusing on treatment of mIDH1 AML patients […]

MNSCT 2024 Meeting

MNSCT 2024 Meeting  Date: 21 November 2024 Venue: Grand Hotel, Lund, Sweden or online Registration: https://mkon.nu/mnsct_2024/registration Program 12:00-12:55   Lunch, registration starts at 11.45 13:00-13:05   Welcome/Introduction  (Assoc. Prof. Andreas Björklund, Stockholm, Assoc. Prof. Jörg Cammenga, Lund) Session 1:             13:05-13:45   Prof. Dr. Thomas Schröder, University Hospital Essen, Essen Germany -- “Pharmacological preemptive and prophylactic approaches to prevent/treat relapse of   myeloid neoplasms after allo SCT” […]

AML Course Day 10 September 2025

The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current diagnostics and therapeutics, the latest with regard to MRD as well as clinically inclined discussions on emergencies and infectious problems in AML. The AML Course […]